相关实验视频
Updated: Jul 1, 2025

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.5K
体外膜氧化对凝血系统的影响
Tianlong Wang1, Weidong Yan2, Mingru Zhang3
1Department of Cardiopulmonary Bypass, Fuwai Hospital, National Center for Cardiovascular Disease, State Key Laboratory of Cardiovascular Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College.
Journal of visualized experiments : JoVE
|March 11, 2024
概括
长期清醒的体外膜氧化 (ECMO) 影响绵羊的凝血. 静脉动脉ECMO比静脉静脉ECMO显示出更高的激活部分血栓形成时间和血栓时间,在两组中都有脏梗塞.
科学领域:
- 心血管科学 心血管科学
- 血液学 血液学 血液学
- 医疗技术 医疗技术 医学技术
背景情况:
- 身体外膜氧化 (ECMO) 是一种生命支持疗法.
- 了解ECMO对凝血的影响对于患者安全至关重要.
- 长期清醒的ECMO会带来独特的生理挑战.
研究的目的:
- 调查长期清醒静脉动脉 (V-A) ECMO与静脉 (V-V) ECMO对绵羊模型凝血系统的影响.
- 为了比较V-A和V-V ECMO配置之间的凝血参数.
- 评估与清醒ECMO相关的潜在器官损伤.
主要方法:
- 十只健康的羊被分为V-A ECMO和V-V ECMO组 (每组n=5).
- 绵羊在ECMO启动后的7天内保持清醒.
- 监测了激活的凝血时间 (ACT),激活的部分血栓形成时间 (APTT) 和血栓时间 (TT).
- 氨酸剂量进行了调整,以保持目标ACT (220-250秒).
- 实验后检查了组织学.
主要成果:
- 无论是V-A和V-V ECMO组都需要增加肝素剂量,达到大约60 IU/kg/min.
- 与V-V ECMO组相比,V-A ECMO组显示出明显更高的APTT和TT值.
- 尽管在正常范围内波动,但实验室结果并不能完全预测两组观察到的脏梗塞焦点.
结论:
- 长期清醒的ECMO,特别是V-A配置,改变凝血参数不同于V-V ECMO.
- 在两种ECMO配置中都出现了损伤 (心脏病发作),这表明除了凝血之外还有潜在的系统性影响.
- 需要进一步的研究,以阐明在清醒 ECMO 期间器官损伤的机制,并优化抗凝策略.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Oxygen Transport in the Blood
2.7K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.7K
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K

